ASKUL (2678) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
15 Sep, 2026Executive summary
Consolidated net sales for Q1 FY5/2027 were ¥112.3 billion, down 8.2% year-over-year, reflecting ongoing recovery from a prior ransomware attack and challenging market conditions.
Operating loss was ¥418 million, compared to a ¥1.05 billion profit in Q1 FY5/2026; loss attributable to owners of parent was ¥508 million versus a profit of ¥344 million a year earlier.
Structural reforms are progressing, with improvements in gross profit margin, variable logistics cost ratio, and fixed cost ratio.
AI-driven sales and marketing initiatives, cost reductions, and operational efficiency are being prioritized for medium- to long-term growth.
Q2 onward is expected to be pivotal for returning to growth, with accelerated execution of key strategies.
Financial highlights
Q1 FY5/2027 consolidated net sales: ¥112.3 billion, down 8.2% year-over-year.
Gross profit: ¥26.2 billion, down 13.7% year-over-year; gross profit margin: 23.3%, down 1.5 percentage points.
Operating profit: -¥418 million (loss), compared to ¥1.05 billion profit in Q1 FY5/2026.
Ordinary profit: -¥452 million; profit attributable to owners of parent: -¥508 million.
SG&A expenses: ¥26.6 billion, down 9.1% year-over-year; ratio to net sales: 23.7%.
Comprehensive income was negative ¥412 million, compared to ¥426 million in the prior year.
Basic earnings per share was negative ¥5.68, down from ¥3.73 in the previous year.
Outlook and guidance
Full-year forecast for FY5/2027 remains unchanged: net sales of ¥490 billion (+22.4% YoY), operating profit of ¥7 billion, ordinary profit of ¥6.3 billion, and profit attributable to owners of parent of ¥4 billion (EPS: ¥44.68).
Dividend forecast is ¥20 per share for the year, unchanged from previous guidance.
Recovery in EBITDA is expected in FY5/2027, with Q2 and beyond seen as a turning point for growth.
Full-year sales aim to return to pre-cyberattack levels.
Medium-term strategy targets original products to reach 50% of sales by FY5/2032.
Latest events from ASKUL
- Record-high sales and profits driven by B-to-B growth and extraordinary income; FY5/2025 sales to rise.2678
Q4 2024 - Net sales up 4.7% YoY, but operating profit down 8.9% on higher costs and FX margin pressure.2678
Q1 2025 - Sales rose 2.9% but profit fell on margin pressure; record full-year targets remain.2678
Q2 2025 - Record net sales but sharp profit decline; outlook cut, dividend and buybacks increased.2678
Q3 2025 - Record sales but profits declined sharply on higher costs and FX; recovery eyed for FY5/2027.2678
Q4 2025 - Sales up 3.3% YoY, but profit down 59.1% due to ASKUL Kanto DC and one-time costs.2678
Q1 2026 - Ransomware attack caused a 12.3% sales drop, operating loss, and uncertain outlook.2678
Q2 2026 - Ransomware attack caused sharp sales and profit declines, but recovery and promotions are underway.2678
Q3 2026 - Ransomware attack drove steep losses, but a strong recovery is forecast for the next fiscal year.2678
Q4 2026